- Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective News-Medical.Net
- NIH study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection National Institutes of Health
- Human lung and brain organoids respond differently to SARS-CoV-2 infection in lab tests Medical Xpress
- Basigin does not facilitate SARS-CoV-2 entry, say researchers News-Medical.Net
- Covid-19 Antibodies Reduce Risk of Future Infection, Study Finds Bloomberg Law
- View Full coverage on Google News
Lab study of South African SARS-CoV-2 variant and Moderna vaccine: reduced neutralization, but still protective – News-Medical.Net
ByGoogle News
Feb 25, 2021